Johnson & Johnson (JNJ) Net Shares Issued and Repurchased (2010 - 2012)
Johnson & Johnson's (JNJ) quarterly Net Shares Issued and Repurchased came in at $1.9 million in Q1 2012, down 17.86% year-over-year from $2.3 million in Q1 2011, and down 17.86% quarter-over-quarter from $2.3 million in Q1 2011.
Analysis
Johnson & Johnson (JNJ) Net Shares Issued and Repurchased (2010 - 2012) Analysis & Trends
Johnson & Johnson has disclosed Net Shares Issued and Repurchased across 3 years of filings, most recently posting $1.9 million for Q1 2012.
- In Q1 2012, Net Shares Issued and Repurchased fell 17.86% year-over-year to $1.9 million; the TTM figure through Jan 2012 stood at $1.9 million (down 17.86% YoY), while the FY2012 annual figure was $1.9 million, down 17.86% from the prior year.
- Net Shares Issued and Repurchased came in at $1.9 million for Q1 2012 at Johnson & Johnson, down from $2.3 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $2.3 million in Q1 2011 to a low of $1.4 million in Q1 2010.
- Average Net Shares Issued and Repurchased over 3 years is $1.9 million, with a median of $1.9 million recorded in 2012.
- Year-over-year, Net Shares Issued and Repurchased soared 64.94% in 2011 and declined 17.86% in 2012.
- Over 3 years, Net Shares Issued and Repurchased stood at $1.4 million in 2010, then surged by 64.94% to $2.3 million in 2011, then declined by 17.86% to $1.9 million in 2012.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.9 million in Q1 2012, $2.3 million in Q1 2011, and $1.4 million in Q1 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 1, 2012 | 1.89 Mn |
| Jan 2, 2011 | 2.30 Mn |
| Jan 3, 2010 | 1.39 Mn |